We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Virus Linked to Development of Common Form of Skin Cancer

By LabMedica International staff writers
Posted on 11 Aug 2009
Cancer researchers have linked a virus implicated in the development of a rare, deadly form of skin cancer to the much more common and treatable type of skin cancer, squamous cell carcinoma (SCC).

Investigators from Ohio State University (Columbus, USA) had speculated that the Merkel cell polyomavirus (MCPyV), which could be isolated from patients with the relatively rare skin cancer Merkel cell carcinoma, might also play a role in the development of the milder and more common SCC. More...
To test this hypothesis the investigators used polymerase chain reaction (PCR) with primer sets directed against the large T (LT) antigen and VP1 gene of MCPyV.

The investigators reported in the June 25, 2009, online edition of the Journal of Investigative Dermatology that they had detected MCPyV in 15% (26/177) of SCC DNA samples and 17% (11/63) of adjacent skin DNA samples from 21 of 58 (36%) individuals studied. They did not detect MCPyV in any matched normal blood DNA (0/57), but observed the presence of MCPyV DNA in one of 12 normal mouthwash DNAs. All sequenced SCC samples had a common mutation that shortened the LT antigen, which provided indirect evidence of viral integration into the cancer cells.

"This is indirect evidence that the virus might play a role in causing some cases of squamous cell carcinoma,” said senior author Dr. Amanda E. Toland, assistant professor of molecular virology, immunology, and medical genetics at Ohio State University. "Originally it was thought that this virus caused only this rare skin cancer, but our findings indicate that it is a lot more prevalent than we initially thought. That suggests that the virus may develop a mutation that causes it to integrate into host-cell DNA, and therefore, may play a role in causing the cancer. If it proves to be a cancer-causing virus, and if it proves to be common in the general population, it might be something we should begin screening people for.”

Related Links:
Ohio State University



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.